CUE

Cue Biopharma Inc

Jun 03 • 12:35PM ET

26.18

-2.44 -8.53 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AGEN EDSA GNLX KZIA PYXS VRCA VTVT GALT IMUX SPRO

| Held by: VTI VXF DFAS AVSC DFAU DFMC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.53	Insider Own	10.63%	Shs Outstand	4.05M	Perf Week	28.11%
Market Cap	105.92M	Forward P/E	-	EPS next Y	-9.45	Insider Trans	304.94%	Shs Float	3.62M	Perf Month	-12.29%
Enterprise Value	92.98M	PEG	-	EPS next Q	-1.69	Inst Own	17.63%	Short Float	7.05%	Perf Quarter	188.68%
Income	-19.52M	P/S	3.24	EPS this Y	20.95%	Inst Trans	-1.15%	Short Ratio	0.34	Perf Half Y	46.67%
Sales	32.73M	P/B	3.94	EPS next Y	-42.32%	ROA	-73.49%	Short Interest	0.26M	Perf YTD	185.75%
Book/sh	6.64	P/C	6.47	EPS next 5Y	-	ROE	-138.52%	52W High	41.42 -36.79%	Perf Year	38.15%
Cash/sh	4.05	P/FCF	-	EPS past 3/5Y	42.63% 29.04%	ROIC	-83.13%	52W Low	4.97 426.65%	Perf 3Y	-78.77%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	180.45% 54.16%	Gross Margin	99.01%	Volatility	13.54% 15.72%	Perf 5Y	-93.47%
Dividend TTM	-	EV/Sales	2.84	EPS Y/Y TTM	72.33%	Oper. Margin	-59.83%	ATR (14)	4.02	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.57	Sales Y/Y TTM	309.60%	Profit Margin	-59.65%	RSI (14)	56.14	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.57	EPS Q/Q	78.25%	SMA20	2.54%	Beta	2.53	Target Price	115.00
Payout	-	Debt/Eq	0.16	Sales Q/Q	1250.59%	SMA50	38.46%	Rel Volume	0.10	Prev Close	28.62
Employees	29	LT Debt/Eq	0.09	Earnings	May 14 AMC	SMA200	55.99%	Avg Volume	741.91K	Price	26.18
IPO	Jan 02, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	36,993	Change	-8.53%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)